<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Otsuka Holdings Co., Ltd. Otsuka Group News RSS</title>
    <link>http://www.otsuka.com</link>
    <description>Otsuka Holdings Co., Ltd. Otsuka Group News RSS</description>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="http://www.otsuka.com/en/group_news/rss.php" type="application/rss+xml" rel="self"/>
    <pubDate>Fri, 16 Oct 2026 09:00:00 +0900</pubDate>
    <lastBuildDate>Fri, 16 Oct 2026 09:00:00 +0900</lastBuildDate>
    <ttl>60</ttl>
    <item>
      <title>Otsuka Foods to Revise Price of CRYSTAL GEYSER Product New Price to Take Effect with Deliveries as of January 1, 2027</title>
      <link>https://www.otsukafoods.co.jp/en/news/20261016.html</link>
      <description/>
      <pubDate>Fri, 16 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1633</news_id>
    </item>
    <item>
      <title>TIME Names Recor Medical’s Paradise Ultrasound Renal Denervation System one of the Best Inventions of 2026 (Link to Recor website)</title>
      <link>https://www.recormedical.com/time-names-recor-medical-paradise-ultrasound-rendal-denervation-system-one-of-the-best-inventions-of-2026/</link>
      <description/>
      <pubDate>Fri, 16 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1634</news_id>
    </item>
    <item>
      <title>Paradise Ultrasound Renal Denervation System Receives Good Design Award 2026</title>
      <link>https://www.omd.otsuka.com/en/news/newsreleases/20261015.php</link>
      <description/>
      <pubDate>Thu, 15 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1632</news_id>
    </item>
    <item>
      <title>Next-Generation Cancer Immunotherapy Using Quantum Computing Selected for NEDO Demonstration Program</title>
      <link>https://www.taiho.co.jp/en/release/2026/20261002.html</link>
      <description/>
      <pubDate>Fri, 02 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1630</news_id>
    </item>
    <item>
      <title>Taiho Pharmaceutical and Taiho Oncology Announce Positive Topline Results in Phase 3 AZTOUND Trial Evaluating Oral Azacitidine and Cedazuridine in Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia</title>
      <link>https://www.taiho.co.jp/en/release/2026/20261001.html</link>
      <description/>
      <pubDate>Thu, 01 Oct 2026 09:00:00 +0900</pubDate>
      <news_id>1629</news_id>
    </item>
    <item>
      <title>Otsuka Foods to Revise Prices of Some Products New Prices to Take Effect with Deliveries as of January 1, 2027</title>
      <link>https://www.otsukafoods.co.jp/en/news/20260925.html</link>
      <description/>
      <pubDate>Fri, 25 Sep 2026 09:00:00 +0900</pubDate>
      <news_id>1628</news_id>
    </item>
    <item>
      <title>Otsuka Presents New Phase 3b Results for SIMTRIYO® (centanafadine) Highlighting Consistent Improvements Across ADHD Symptoms, Anxiety, and Associated Features in Adults with ADHD and Comorbid Anxiety Disorders at Psych Congress 2026</title>
      <link>https://www.otsuka.co.jp/en/company/newsreleases/2026/20260924_1.html</link>
      <description/>
      <pubDate>Thu, 24 Sep 2026 09:00:00 +0900</pubDate>
      <news_id>1626</news_id>
    </item>
    <item>
      <title>Otsuka Announces Transformative Phase 3 FUSION Results for Ulefnersen, Bringing the FUS-ALS Community Closer to a Potential Targeted Treatment</title>
      <link>https://www.otsuka.co.jp/en/company/newsreleases/2026/20260922_1.html</link>
      <description/>
      <pubDate>Tue, 22 Sep 2026 09:00:00 +0900</pubDate>
      <news_id>1627</news_id>
    </item>
    <item>
      <title>Otsuka and Jolly Good Launch New Content for FACEDUO Dementia Care Support VR Understanding a New Perspective on Dementia</title>
      <link>https://www.otsuka.co.jp/en/company/newsreleases/2026/20260918_1.html</link>
      <description/>
      <pubDate>Fri, 18 Sep 2026 09:00:00 +0900</pubDate>
      <news_id>1625</news_id>
    </item>
    <item>
      <title>EN Otsuka Pharmaceutical Obtains Marketing Approval for ENOFEED® Liquid for Enteral Use</title>
      <link>https://www.otsukakj.jp/en/news_release/20260916.html</link>
      <description/>
      <pubDate>Wed, 16 Sep 2026 09:00:00 +0900</pubDate>
      <news_id>1624</news_id>
    </item>
  </channel>
</rss>
